Zdrowie i gospodarka · 28/12/2015
FDA Clears KYTRIL Tablets for Approval
The US Food and Drug Administration has determined that KYTRIL tablets, equivalent to 1 milligram and 2 milligram base, were not withdrawn from sale due to safety or effectiveness concerns, paving the way for potential approval of abbreviated new drug applications.
Source: Federal Register — Food and Drug AdministrationOpen original release →